QIAGEN leverages QuantiFERON®-TB technology to advance global efforts against TB TB IGRA testing now accessible in high burden, low resource and decentralized settings Study data also showcased at the ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Health Canada regulatory approval of QuantiFERON®-TB Gold Plus ...

QIAGEN QGEN recently reached a major landmark in the field of tuberculosis (TB) testing. On World TB Day, the company announced that since the lime of its launch, the company’s QuantiFERON blood test ...

New test shows high sensitivity for tuberculosis, providing a faster, near-point-of-care option for early detection and ...

A new test shows promising results for detecting latent tuberculosis infection in resource-limited settings. This is ...

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could ...

Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, per data from the World Health Organization. A person infected with the ...

Data on performance of QuantiFERON-TB Gold In-Tube test (QFT) and tuberculin skin test (TST) in children with active tuberculosis from high burden countries in the context of micronutrient deficiency ...

Healthcare workers should be tested for tuberculosis (TB) when they are hired and should be retested only after an occupational exposure, according to new guidelines issued by the Centers for Disease ...

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, affecting millions annually despite being preventable and curable. Understanding how TB spreads is crucial for both ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis ...